Table 2.
Outcomes for patients receiving deep serratus anterior plane block with ropivacaine or ropivacaine plus DEX.
| Group R (n=36) | Group RD (n=37) | z or χ2-value | p-value | |
|---|---|---|---|---|
| Primary Outcome | ||||
| Median postoperative global QoR-15 score(IQR) | 107 (103–112) | 109.5 (107–114) | −2.414 | 0.016 |
| Secondary Outcomes | ||||
| VAS score in rest (Median, IQR) | ||||
| 1th hour | 0 (0–0.5) | 0 (0–0.5) | −0.624 | 0.533 |
| 6th hour | 0 (0–1) | 0 (0–1) | −0.109 | 0.914 |
| 12th hour | 1 (1–2) | 1 (1–2) | −2.136 | 0.033 |
| 24th hour | 2 (2–3) | 2 (2–3) | −1.909 | 0.056 |
| 48th hour | 2 (1–2) | 2 (1–2) | −1.534 | 0.125 |
| VAS score in movement (median, IQR) | ||||
| 1th hour | 1 (0–1) | 1 (0–1) | −0.575 | 0.566 |
| 6th hour | 1 (0–1) | 1 (0–1) | −1.075 | 0.283 |
| 12th hour | 2 (1–3) | 2 (1–3) | −2.439 | 0.015 |
| 24th hour | 3 (2–3) | 3 (2–3) | −2.051 | 0.040 |
| 48th hour | 2 (2–3) | 2 (2–3) | −1.627 | 0.104 |
| Incidence of PONV(%) | ||||
| 24 h | 11(30.6) | 6 (16.2) | 2.100 | 0.147 |
| 48 h | 8 (22.2) | 5 (13.5) | 0.945 | 0.331 |
| Patient satisfaction score (mean, SD) | 8.28 (0.70) | 8.62 (0.59) | −2.254 | 0.024 |
| Bradycardia (%) | 0 (0) | 1 (2.7) | 0.986 | 0.321 |
| Median sufentanil rescues consumption (μg, IQR) | 14 (12–17) | 14 (12–15) | −2.295 | 0.022 |
| Occurrence of dizziness(%) | 4 (11.1) | 3 (8.1) | 0.190 | 0.663 |
| Occurrence of delirium(%) | 0 (0) | 0 (0) | NA | NA |